Foreign-Trade Zone (FTZ) 43-Battle Creek, Michigan, Notification of Proposed Production Activity, Pfizer, Inc., (Pharmaceutical Products), Kalamazoo, Michigan, 26433-26434 [2017-11835]
Download as PDF
Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices
H. Other Information
BROADCASTING BOARD OF
GOVERNORS
Non Discrimination Statement
sradovich on DSK3GMQ082PROD with NOTICES
In accordance with Federal civil
rights law and U.S. Department of
Agriculture (USDA) civil rights
regulations and policies, the USDA, its
Agencies, offices, and employees, and
institutions participating in or
administering USDA programs are
prohibited from discriminating based on
race, color, national origin, religion, sex,
gender identity (including gender
expression), sexual orientation,
disability, age, marital status, family/
parental status, income derived from a
public assistance program, political
beliefs, or reprisal or retaliation for prior
civil rights activity, in any program or
activity conducted or funded by USDA
(not all bases apply to all programs).
Remedies and complaint filing
deadlines vary by program or incident.
Persons with disabilities who require
alternative means of communication for
program information (e.g., Braille, large
print, audiotape, American Sign
Language, etc.) should contact the
responsible Agency or USDA’s TARGET
Center at (202) 720–2600 (voice and
TTY) or contact USDA through the
Federal Relay Service at (800) 877–8339.
Additionally, program information may
be made available in languages other
than English.
To file a program discrimination
complaint, complete the USDA Program
Discrimination Complaint Form, AD–
3027, found online at https://
www.ascr.usda.gov/complaint_filing_
cust.html and at any USDA office or
write a letter addressed to USDA and
provide in the letter all of the
information requested in the form. To
request a copy of the complaint form,
call (866) 632–9992. Submit your
completed form or letter to USDA by:
(1) Mail: U.S. Department of
Agriculture, Office of the Assistant
Secretary for Civil Rights, 1400
Independence Avenue SW.,
Washington, DC 20250–9410;
(2) Fax: (202) 690–7442; or
(3) Email: program.intake@usda.gov.
Dated: May 26, 2017.
Chadwick O. Parker,
Acting Administrator, Rural BusinessCooperative Service.
[FR Doc. 2017–11739 Filed 6–6–17; 8:45 am]
BILLING CODE 3410–XY–P
VerDate Sep<11>2014
16:37 Jun 06, 2017
Jkt 241001
Request for Comments on the
Broadcasting Board of Governors’
Implementation of a Comprehensive
Plan for Reorganizing the Executive
Branch
Broadcasting Board of
Governors (BBG).
ACTION: Request for comments.
AGENCY:
Executive Order 13781,
‘‘Comprehensive Plan for Reorganizing
the Executive Branch,’’ signed into
effect on March 13, 2017, directs the
Director of the Office of Management
and Budget (OMB) to present the
President with a plan that recommends
ways to reorganize the executive branch
and eliminate unnecessary agencies. As
part of this process, the Broadcasting
Board of Governors will be submitting a
proposal for reorganization to OMB.
This request for comments seeks public
input on potential reforms at the BBG
that would increase the efficiency,
effectiveness, and accountability of the
agency. These comments will also be
considered in the development of the
BBG’s 2018–2022 Strategic Plan.
The BBG is the federal agency charged
with carrying out U.S. Government
funded international media, overseeing
the operations of five media networks:
the Voice of America (VOA), Radio and
TV Marti, Radio Free Europe/Radio
Liberty (RFE/RL), Radio Free Asia
(RFA), and the Middle East
Broadcasting Networks (MBN).
DATES: Submit either electronic
comments or information by June 30,
2017. We will not accept comments by
fax or paper delivery.
ADDRESSES: Submit comments through
the BBG Web site at https://
www.bbg.gov/submit-your-ideas/.
FOR FURTHER INFORMATION CONTACT: Matt
Ciepielowski at 202–203–4845.
SUPPLEMENTARY INFORMATION: Through
this request for comments, the BBG is
seeking initial feedback from a broad
range of stakeholders on questions that
will contribute to the BBG’s proposal to
OMB in accordance with Executive
Order 13781 and the BBG’s 2018–2022
Strategic Plan. This request for
comments is for information-gathering
and fact-finding purposes only, and
should not be construed as a solicitation
or as an obligation on the part of the
BBG to agree with submitted comments
or to make recommendations regarding
specific issues identified in public
comments. The BBG requests that
respondents generally address the
following overarching questions:
SUMMARY:
PO 00000
Frm 00011
Fmt 4703
Sfmt 4703
26433
• What are the most important or
effective projects or programs that the
BBG undertakes?
• Do you think that there are any
changes that BBG could make to
increase the efficiency, effectiveness,
and accountability of its media
networks or the agency itself? If so,
please describe those changes.
• Would you propose reorganizing
any parts or aspects of the BBG or its
media networks to increase efficiency,
effectiveness, and accountability? If so,
how?
• In today’s changing media
landscape, how should the BBG adapt to
best serve its mission to inform, engage,
and connect people around the world in
support of freedom and democracy?
Oanh Tran,
Director of Board Operations, Broadcasting
Board of Governors.
[FR Doc. 2017–11832 Filed 6–6–17; 8:45 am]
BILLING CODE 86100–01–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–27–2017]
Foreign-Trade Zone (FTZ) 43—Battle
Creek, Michigan, Notification of
Proposed Production Activity, Pfizer,
Inc., (Pharmaceutical Products),
Kalamazoo, Michigan
Pfizer Inc. (Pfizer) submitted a
notification of proposed production
activity to the FTZ Board for its facility
in Kalamazoo, Michigan within
Subzone 43E. The notification
conforming to the requirements of the
regulations of the FTZ Board (15 CFR
400.22) was received on April 12, 2017.
Pfizer already has authority to
produce certain pharmaceutical
products within Subzone 43E. The
current request would add finished
products and a foreign status material/
component to the scope of authority.
Pursuant to 15 CFR 400.14(b),
additional FTZ authority would be
limited to the specific foreign-status
material/component and specific
finished products described in the
submitted notification (as described
below) and subsequently authorized by
the FTZ Board.
Production under FTZ procedures
could exempt Pfizer from customs duty
payments on the foreign-status material/
components used in export production.
On its domestic sales, Pfizer would be
able to choose the duty rate during
customs entry procedures that apply to
crisaborole (EucrisaTM) (duty free) in
finished product and bulk form for the
E:\FR\FM\07JNN1.SGM
07JNN1
26434
Federal Register / Vol. 82, No. 108 / Wednesday, June 7, 2017 / Notices
foreign-status material/component
noted below and in the existing scope
of authority. Customs duties also could
possibly be deferred or reduced on
foreign-status production equipment.
The material/component sourced
from abroad is crisaborole—active
pharmaceutical ingredient (duty rate
6.5%).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary at the address below. The
closing period for their receipt is July
17, 2017.
A copy of the notification will be
available for public inspection at the
Office of the Executive Secretary,
Foreign-Trade Zones Board, Room
21013, U.S. Department of Commerce,
1401 Constitution Avenue NW.,
Washington, DC 20230–0002, and in the
‘‘Reading Room’’ section of the Board’s
Web site, which is accessible via
www.trade.gov/ftz.
For further information, contact
Christopher Wedderburn at
Chris.Wedderburn@trade.gov or (202)
482–1963.
Dated: June 2, 2017.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2017–11835 Filed 6–6–17; 8:45 am]
BILLING CODE 3510–DS–P
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
Dated: June 2, 2017.
Andrew McGilvray,
Executive Secretary.
[B–26–2017]
sradovich on DSK3GMQ082PROD with NOTICES
Foreign-Trade Zone (FTZ) 80—San
Antonio, Texas, Notification of
Proposed Production Activity, DPT
Laboratories, Ltd., (Pharmaceutical
Products), San Antonio, Texas
[FR Doc. 2017–11833 Filed 6–6–17; 8:45 am]
BILLING CODE 3510–DS–P
DPT Laboratories, Ltd. (DPT)
submitted a notification of proposed
production activity to the FTZ Board for
its facilities in San Antonio, Texas. The
notification conforming to the
requirements of the regulations of the
FTZ Board (15 CFR 400.22) was
received on April 17, 2017.
The request indicates that a separate
application for subzone designation for
two DPT facilities under FTZ 80 will be
submitted. Any such application would
be processed under Section 400.38 of
the Board’s regulations. The facilities
will be used to produce certain
pharmaceutical products. Pursuant to 15
CFR 400.14(b), FTZ activity would be
limited to the specific foreign-status
material/component and specific
finished products described in the
submitted notification (as described
VerDate Sep<11>2014
16:37 Jun 06, 2017
Jkt 241001
below) and subsequently authorized by
the FTZ Board.
Production under FTZ procedures
could exempt DPT from customs duty
payments on the foreign-status material/
componens used in export production.
On its domestic sales, DPT would be
able to choose the duty rate during
customs entry procedures that apply to
crisaborole (EucrisaTM) (duty free) in
finished product and bulk form for the
foreign-status input noted below.
Customs duties also could possibly be
deferred or reduced on foreign-status
production equipment.
The material/component sourced
from abroad is crisaborole—active
pharmaceutical ingredient (duty rate
6.5%).
Public comment is invited from
interested parties. Submissions shall be
addressed to the Board’s Executive
Secretary at the address below. The
closing period for their receipt is July
17, 2017.
A copy of the notification will be
available for public inspection at the
Office of the Executive Secretary,
Foreign-Trade Zones Board, Room
21013, U.S. Department of Commerce,
1401 Constitution Avenue NW.,
Washington, DC 20230–0002, and in the
‘‘Reading Room’’ section of the Board’s
Web site, which is accessible via
www.trade.gov/ftz.
For further information, contact
Christopher Wedderburn at
Chris.Wedderburn@trade.gov or (202)
482–1963.
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B–28–2017]
Foreign-Trade Zone 186—Waterville,
Maine Application for Production
Authority, Flemish Master Weavers,
Subzone 186A, (Machine-Made Woven
Area Rugs), Sanford, Maine
An application has been submitted to
the Foreign-Trade Zones (FTZ) Board by
the City of Waterville, Maine, grantee of
FTZ 186, requesting production
authority on behalf of Flemish Master
Weavers (FMW), located within
Subzone 186A in Sanford, Maine. The
application conforming to the
requirements of the regulations of the
FTZ Board (15 CFR 400.23) was
docketed on April 18, 2017.
PO 00000
Frm 00012
Fmt 4703
Sfmt 9990
The FMW facility (127 employees,
4.08 acres) is used for the production of
machine-made woven area rugs. FMW
already has restricted FTZ authority to
produce area rugs using polypropylene
and polyester yarns in privileged foreign
status (19 CFR 146.41), which precludes
inverted tariff benefits on those inputs
(see 81 FR 51850, August 5, 2016).
The pending application requests
authority for FMW to use imported
continuous filament polypropylene yarn
in non-privileged foreign status (19 CFR
146.42). If the application were
approved, on its domestic sales, FMW
would be able to choose the duty rate
during customs entry procedures that
applies to machine-made woven area
rugs (duty free) for the imported
continuous filament polypropylene yarn
(otherwise dutiable at 8%). Customs
duties also could possibly be deferred or
reduced on foreign-status production
equipment. The request indicates that
the savings from FTZ procedures would
help improve the plant’s international
competitiveness.
In accordance with the FTZ Board’s
regulations, Diane Finver of the FTZ
Staff is designated examiner to evaluate
and analyze the facts and information
presented in the application and case
record and to report findings and
recommendations to the FTZ Board.
Public comment is invited from
interested parties. Submissions shall be
addressed to the FTZ Board’s Executive
Secretary at the address below. The
closing period for their receipt is August
7, 2017. Rebuttal comments in response
to material submitted during the
foregoing period may be submitted
during the subsequent 15-day period to
August 21, 2017.
A copy of the application will be
available for public inspection at the
Office of the Executive Secretary,
Foreign-Trade Zones Board, Room
21013, U.S. Department of Commerce,
1401 Constitution Avenue NW.,
Washington, DC 20230–0002, and in the
‘‘Reading Room’’ section of the FTZ
Board’s Web site, which is accessible
via www.trade.gov/ftz.
For further information, contact Diane
Finver at Diane.Finver@trade.gov or
(202) 482–1367.
Dated: June 2, 2017.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2017–11837 Filed 6–6–17; 8:45 am]
BILLING CODE 3510–DS–P
E:\FR\FM\07JNN1.SGM
07JNN1
Agencies
[Federal Register Volume 82, Number 108 (Wednesday, June 7, 2017)]
[Notices]
[Pages 26433-26434]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-11835]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-27-2017]
Foreign-Trade Zone (FTZ) 43--Battle Creek, Michigan, Notification
of Proposed Production Activity, Pfizer, Inc., (Pharmaceutical
Products), Kalamazoo, Michigan
Pfizer Inc. (Pfizer) submitted a notification of proposed
production activity to the FTZ Board for its facility in Kalamazoo,
Michigan within Subzone 43E. The notification conforming to the
requirements of the regulations of the FTZ Board (15 CFR 400.22) was
received on April 12, 2017.
Pfizer already has authority to produce certain pharmaceutical
products within Subzone 43E. The current request would add finished
products and a foreign status material/component to the scope of
authority. Pursuant to 15 CFR 400.14(b), additional FTZ authority would
be limited to the specific foreign-status material/component and
specific finished products described in the submitted notification (as
described below) and subsequently authorized by the FTZ Board.
Production under FTZ procedures could exempt Pfizer from customs
duty payments on the foreign-status material/components used in export
production. On its domestic sales, Pfizer would be able to choose the
duty rate during customs entry procedures that apply to crisaborole
(EucrisaTM) (duty free) in finished product and bulk form
for the
[[Page 26434]]
foreign-status material/component noted below and in the existing scope
of authority. Customs duties also could possibly be deferred or reduced
on foreign-status production equipment.
The material/component sourced from abroad is crisaborole--active
pharmaceutical ingredient (duty rate 6.5%).
Public comment is invited from interested parties. Submissions
shall be addressed to the Board's Executive Secretary at the address
below. The closing period for their receipt is July 17, 2017.
A copy of the notification will be available for public inspection
at the Office of the Executive Secretary, Foreign-Trade Zones Board,
Room 21013, U.S. Department of Commerce, 1401 Constitution Avenue NW.,
Washington, DC 20230-0002, and in the ``Reading Room'' section of the
Board's Web site, which is accessible via www.trade.gov/ftz.
For further information, contact Christopher Wedderburn at
Chris.Wedderburn@trade.gov or (202) 482-1963.
Dated: June 2, 2017.
Andrew McGilvray,
Executive Secretary.
[FR Doc. 2017-11835 Filed 6-6-17; 8:45 am]
BILLING CODE 3510-DS-P